Diversified Trust’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12,287
| Closed | -$46K | – | 871 |
|
|
2023
Q4 | $46K | Hold |
12,287
| – | – | ﹤0.01% | 850 |
|
|
2023
Q3 | $26K | Sell |
12,287
-11,357
| -48% | -$24.1K | ﹤0.01% | 816 |
|
|
2023
Q2 | $113K | Buy |
23,644
+11,357
| +92% | +$54.1K | ﹤0.01% | 792 |
|
|
2023
Q1 | $70K | Hold |
12,287
| – | – | ﹤0.01% | 795 |
|
|
2022
Q4 | $124K | Buy |
12,287
+615
| +5% | +$6.21K | 0.01% | 759 |
|
|
2022
Q3 | $262K | Sell |
11,672
-386
| -3% | -$8.66K | 0.01% | 587 |
|
|
2022
Q2 | $299K | Hold |
12,058
| – | – | 0.01% | 564 |
|
|
2022
Q1 | $467K | Hold |
12,058
| – | – | 0.02% | 483 |
|
|
2021
Q4 | $706K | Buy |
12,058
+754
| +7% | +$44.1K | 0.02% | 347 |
|
|
2021
Q3 | $670K | Hold |
11,304
| – | – | 0.02% | 309 |
|
|
2021
Q2 | $981K | Buy |
11,304
+5,943
| +111% | +$516K | 0.04% | 245 |
|
|
2021
Q1 | $442K | Buy |
+5,361
| New | +$442K | 0.02% | 411 |
|